Amgen's obesity drug candidate, MariTide (maridebart cafraglutide, formerly AMG 133), has brought forward promising results in a Phase II clinical trial, sparking hope for a new and effective treatment for obesity. With its innovative design and impressive efficacy, MariTide is positioned as a
Beckman Coulter Life Sciences, a subsidiary of Danaher Corporation, has announced the launch of the Cydem VT Automated Clone Screening System, an innovative platform designed to transform the world of drug discovery through advanced laboratory automation and innovation. This groundbreaking
Platelets play an essential role in human physiology, particularly during the clotting process in response to injury. Despite their importance, the comprehension and measurement of platelet functionality have consistently posed challenges for scientists and clinicians. This issue has become even
Androgenetic alopecia (AGA), a condition affecting millions of men globally, is characterized by the progressive miniaturization of hair follicles, leading to significant hair loss. This condition is primarily caused by dihydrotestosterone (DHT), a testosterone derivative, as well as elevated
A promising new approach in battling Alzheimer's disease has emerged, involving an innovative nasal spray drug that targets a specific brain enzyme. Researchers at Università Cattolica and Fondazione Policlinico Universitario A. Gemelli IRCCS have discovered that inhibiting the enzyme
The University of Southern California (USC) has entered into a groundbreaking partnership with Autobahn Labs to speed up early-stage drug discovery, marking a transformative step in translating academic research into effective treatments. This collaboration aims to leverage USC's vast scientific
